thomas kurian wife allison
Several people who have attended the meetings over the years said all the top Oracle executives have assigned seats - including Ellison himself, the two co-CEOs Safra Catz and Mark Hurd, and. Both groups found the tool easy to use, with SUS scores of 82.5-85 on a scale of 1-100; we did not observe differences according to patient age or gene mutation. Her Age,. To construct a cohort of metastatic breast cancer (MBC) patients, we applied natural language processing techniques within a semisupervised machine learning framework to linked EMR-California Cancer Registry (CCR) data.We studied all female patients treated at Stanford Health Care with an incident breast cancer diagnosis from 2000 to 2014. Most women (92%) had used oral contraceptive pills. Kapoor, P. M., Mavaddat, N. n., Choudhury, P. P., Wilcox, A. N., Lindstrm, S. n., Behrens, S. n., Michailidou, K. n., Dennis, J. n., Bolla, M. K., Wang, Q. n., Jung, A. n., Abu-Ful, Z. n., Ahearn, T. n., Andrulis, I. L., Anton-Culver, H. n., Arndt, V. n., Aronson, K. J., Auer, P. L., Freeman, L. E., Becher, H. n., Beckmann, M. W., Beeghly-Fadiel, A. n., Benitez, J. n., Bernstein, L. n., Bojesen, S. E., Brauch, H. n., Brenner, H. n., Brning, T. n., Cai, Q. n., Campa, D. n., Canzian, F. n., Carracedo, A. n., Carter, B. D., Castelao, J. E., Chanock, S. J., Chatterjee, N. n., Chenevix-Trench, G. n., Clarke, C. L., Couch, F. J., Cox, A. n., Cross, S. S., Czene, K. n., Dai, J. Y., Earp, H. S., Ekici, A. The study evaluates if a 6-month course of oral lovastatin at 80 mg/day would decrease View Original Notice Allison, Thomas "Tommy" Thomas Edward "Tommy" Allison, age 75, of Gr Research suggests that adherence to the 2012 ACS Guideline might lower breast cancer risk, but there is limited evidence that this applies to women at increased familial and genetic risk of breast cancer.Using the Breast Cancer Family Registry (BCFR), a cohort enriched for increased familial and genetic risk of breast cancer, we examined adherence to three 2020 ACS Guideline recommendations (weight management (body mass index), physical activity, and alcohol consumption) with breast cancer risk in 9615 women. Compared with white women, black women had statistically significantly higher rates of triple-negative breast cancer at all ages but statistically significantly lower rates of HR(+)/HER2(-) breast cancers after age 35 years (all P < .05). Together with colleagues at the University of Michigan, Emory University and University of Southern California, I co-lead the GIFT study, a randomized clinical trial of approaches to cascade genetic testing of relatives, which is funded by the National Cancer Institute's Cancer Moonshot (U01 CA254822) through the Inherited Cancer Syndrome Collaborative.I am Principal Investigator of the Oncoshare project, a breast cancer outcomes research initiative using integrated data from electronic medical records at Stanford and Sutter Health, linked to the population-based SEER registry. Bianca Carelli Age 2023, Height, Weight, Wikipedia, Boyfriend, Instagram, Net Worth. Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System. Gruber, J. J., Chen, J. n., Geller, B. n., Jger, N. n., Lipchik, A. M., Wang, G. n., Kurian, A. W., Ford, J. M., Snyder, M. P. Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015. Genetic testing after diagnosis of breast cancer is common, but little is known about the influence of the surgeon on the variation in testing.To quantify and explain the association of attending surgeon with rates of genetic testing after diagnosis of breast cancer.This population-based study identified 7810 women with stages 0 to II breast cancer treated between July 1, 2013, and August 31, 2015, through the Surveillance, Epidemiology, and End Results registries for the state of Georgia, as well as Los Angeles County, California. Half (54.7%) used AIs only, 27.6% used tamoxifen only and 17.7% used both tamoxifen and AIs sequentially. View details for DOI 10.1016/j.ajhg.2021.05.013. Women reported chemotherapy recommendations, the receipt of chemotherapy, testing experiences, and decision satisfaction. The odds ratio (OR) per unit standard deviation was consistent between validations (OR, 1.45 [95% CI, 1.39 to 1.52]; OR 1.47 [95% CI, 1.45 to 1.49]). Vigen, C., Gomez, S. L., Sposto, R., Lu, Y., Kwan, M., John, E., Monroe, K., Keegan, T. H., Shariff-Marco, S., Kurian, A. W. Oncoshare: lessons learned from building an integrated multi-institutional database for comparative effectiveness research. Stage was the only significant predictor of GCC receipt for all subtypes (stage II vs III: odds ratio [OR] for HR+/HER2+, 0.20; 95% confidence interval [CI], 0.08-0.50; OR for HR-/HER2+, 0.13; 95% CI, 0.07-0.25; OR for HR-/HER2-, 3.86; 95% CI, 1.55-9.62; OR for HR+/HER2-, 2.81; 95% CI, 1.63-5.80).GCC is high among YAs with breast cancer. Most patients (82%; 95% CI, 70% to 90%) recalled that a risk-reducing intervention (screening, medication, or surgery) was recommended, and most patients (85%; 95% CI, 72% to 93%) adhered to the recommendation. Ethnic variations in breast cancer epidemiology and genetics have necessitated investigation of the spectra of BRCA1 and BRCA2 mutations in different populations. HER2 mutated cancer responds to treatment with neratinib. Compared to women seen at only one organization, the last group had similar-length initial care episodes, but more frequently had multiple episodes and longer observation periods.Linking EHR data from neighboring systems can enhance our information on care trajectories, but careful consideration of the complexity of the treatment process and data generating mechanisms is necessary to make valid inferences.If analyzed as a timeline, and with careful characterization of diagnostic tests, surgical interventions, and type and frequency of physician encounters, the pathways taken by women through their breast cancer episode may lead to better understanding of patient decisions. To the authors' knowledge, the magnitude of benefit is unknown.The authors used data from the Surveillance, Epidemiology, and End Results (SEER) program regarding all women diagnosed with American Joint Committee on Cancer stage 0 to stage III unilateral breast cancer in California from 1998 through 2015 and treated with BLM versus breast-conserving therapy including surgery and radiotherapy (BCT) or unilateral mastectomy (ULM). Yoganathan S, Arunachal G, Sudhakar SV, Rajaraman V, Thomas M, Danda S Thomas Kurian Wife Allison The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, . Each was staged as T1N0M0. Jayasekera, J., Zhao, A., Schechter, C., Lowry, K., Yeh, J. M., Schwartz, M. D., O'Neill, S., Wernli, K. J., Stout, N., Mandelblatt, J., Kurian, A. W., Isaacs, C. Chemotherapy Regimens Received by Women with BRCA1/2 Pathogenic Variants for Early-Stage Breast Cancer Treatment. Breast cancer incidence rates in women of Asian descent have been increasing in the United States (U.S.) and Asia.In a case-control study of Asian American women from the San Francisco Bay Area, we assessed associations with birthplace and migration-related characteristics and compared risk factors between Asian American and non-Hispanic White women by birthplace and birth cohort.Birthplace and migration-related characteristics were associated with breast cancer risk only among women in the younger birth cohort (1951-1984) that comprised 355 cases diagnosed at age 55 years and 276 sister and population controls. [14], American Society for Clinical Investigation, "Researchers 'lase' a trail to early detection of breast tumors", "Risk of breast cancer mutations underestimated for Asian women, Stanford study shows", "No higher risk of breast cancer for women who don't have BRCA mutation but have relatives who do", "Online tool helps those with BRCA mutations understand options", "New Research Findings on Breast Cancer Surgery Survival Rates", "Ovarian cancer patients undertested for mutations that could guide clinical care", https://en.wikipedia.org/w/index.php?title=Allison_Kurian&oldid=1034572796, This page was last edited on 20 July 2021, at 17:12. A., Kurian, A. W., Das, A. K., Desai, M. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. View details for DOI 10.1001/jamaoncol.2021.6204. Surgery after initial lumpectomy declined by 16% (P. The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Kurian joined Oracle in 1996, initially holding various product management and development positions. Hazard ratios for all-cause mortality were not consistently affected by source of comorbidity information; the hazard ratio was lower for diabetes, but higher for the other comorbidities when medical record versus self-report was used. Wapnir, I. L., Kingham, K. E., Mills, M., Ford, J. M., Kurian, A. W. Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations. Thomas Kurian was born to P.C. Adjusting for baseline-model variables decreased disparity primarily by reducing the hazard ratio for African Americans to 1.13 (0.96 - 1.33). Park, H. A., Neumeyer, S., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Ahearn, T. U., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Arndt, V., Aronson, K. J., Augustinsson, A., Baten, A., Beane Freeman, L. E., Becher, H., Beckmann, M. W., Behrens, S., Benitez, J., Bermisheva, M., Bogdanova, N. V., Bojesen, S. E., Brauch, H., Brenner, H., Brucker, S. Y., Burwinkel, B., Campa, D., Canzian, F., Castelao, J. E., Chanock, S. J., Chenevix-Trench, G., Clarke, C. L., Conroy, D. M., Couch, F. J., Cox, A., Cross, S. S., Czene, K., Daly, M. B., Devilee, P., Drk, T., Dos-Santos-Silva, I., Dwek, M., Eccles, D. M., Eliassen, A. H., Engel, C., Eriksson, M., Evans, D. G., Fasching, P. A., Flyger, H., Fritschi, L., Garca-Closas, M., Garca-Senz, J. Apart from that, Thomas Kurian older brother isa private equity investor in Bangalore. These findings warrant intensive surveillance for second breast cancers in women with HR-negative tumors. BRCA1/2 mutation carriers were enrolled from cancer genetics clinics in Hong Kong and California according to standardized entry criteria. Li-Fraumeni syndrome is a highly penetrant cancer syndrome associated with a high lifetime risk for cancer, including soft tissue sarcomas, osteosarcomas, premenopausal breast cancer, colon cancer, gastric cancer, adrenocortical carcinoma, and brain tumors. Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women's Health Initiative. II cohort will permit extended assays of tolerability, initial estimates of efficacy, and the A., Desai, M., Varma, S., Seto, T., Rigdon, J., Jensen, K. C., Troxell, M. L., Gomez, S. L., Das, A. K., Beck, A. H., Kurian, A. W., West, R. B. Use of genetic counseling was similar between language groups. Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer, Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole, Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer. View details for DOI 10.1007/s10549-016-4076-5, View details for Web of Science ID 000393023500014. All patients underwent comprehensive BRCA1/2 genotyping. A large corpus of unannotated mammography reports (300,000) was used to learn the context of the key-terms using a distributional semantics approach, and the trained model was applied to generate context-aware vector representations of the reports annotated with BI-RADS category(22,091). Lowry, K. P., Callaway, K. A., Lee, J. M., Zhang, F., Ross-Degnan, D., Wharam, J. F., Kerlikowske, K., Wernli, K. J., Kurian, A. W., Henderson, L. M., Stout, N. K. Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations. We undertook the current analysis to determine population-based distributions of breast cancer subtypes among six ethnic Asian groups in California. This study is the next step in a larger research effort to Approximately one-third (34.5% [1350 of 3910] of patients had an elevated risk of mutation carriage, and 27.0% (1056 of 3910) overall had genetic testing. During the follow-up period, 9% of patients (95% CI, 3% to 19%) developed second cancers, and in 14% of patients (95% CI, 7% to 26%), a first-degree relative developed cancer, some of which were detected by recommended screening.Patients with a pathogenic variant in a less familiar cancer susceptibility gene report high adherence to risk-reducing interventions. HLA imputation was performed using SNP2HLA on 10,886 quality-controlled variants within the 15-55Mb region on chromosome 6. A larger screening trial is needed to determine which subgroups of high-risk women will benefit and whether the identification of malignant and high-risk lesions at an early stage will impact breast carcinoma incidence and mortality. B., John, E. M., Joseph, V. n., Konstantopoulou, I. n., Kurian, A. W., Kwong, A. n., Landucci, E. n., Lesueur, F. n., Loud, J. T., Machackova, E. n., Mai, P. L., Majidzadeh-A, K. n., Manoukian, S. n., Montagna, M. n., Moserle, L. n., Mulligan, A. M., Nathanson, K. L., Nevanlinna, H. n., Ngeow Yuen Ye, J. n., Nikitina-Zake, L. n., Offit, K. n., Olah, E. n., Olopade, O. I., Osorio, A. n., Papi, L. n., Park, S. K., Pedersen, I. S., Perez-Segura, P. n., Petersen, A. H., Pinto, P. n., Porfirio, B. n., Pujana, M. A., Radice, P. n., Rantala, J. n., Rashid, M. U., Rosenzweig, B. n., Rossing, M. n., Santamaria, M. n., Schmutzler, R. K., Senter, L. n., Simard, J. n., Singer, C. F., Solano, A. R., Southey, M. C., Steele, L. n., Steinsnyder, Z. n., Stoppa-Lyonnet, D. n., Tan, Y. Y., Teixeira, M. R., Teo, S. H., Terry, M. B., Thomassen, M. n., Toland, A. E., Torres-Esquius, S. n., Tung, N. n., van Asperen, C. J., Vega, A. n., Viel, A. n., Vierstraete, J. n., Wappenschmidt, B. n., Weitzel, J. N., Wieme, G. n., Yoon, S. Y., Zorn, K. K., McGuffog, L. n., Parsons, M. T., Hamann, U. n., Greene, M. H., Kirk, J. However, few data exist for racial/ethnic groups other than non-Latina whites. Wang, A., Wakelee, H. A., Aragaki, A. K., Tang, J. Y., Kurian, A. W., Manson, J. E., Stefanick, M. L. Equivalent survival after nipple-sparing compared to non-nipple-sparing mastectomy: data from California, 1988-2013. Adjusted time to next treatment hazard ratio was 0.89 (95% confidence interval: 0.62-1.29). B., Zhou, R., Kozlov, A., DeMartini, W., Chen, S., Okamoto, S., Ikeda, D. M., Mattonen, S. A., Napel, S., Alkim, E., Sledge, G. W., Kurian, A. W., Liu, M., Telli, M. L., Itakura, H. Harnessing artificial intelligence to automate delineation of volumetric breast cancers from magnetic resonance imaging to improve tumor characterization. Hong Kong and California according to standardized entry criteria an Integrated Health System non-Latina whites was similar between groups! In Short-Term breast cancer subtypes Among six ethnic Asian groups in California that, kurian... Of Science ID 000393023500014 used oral contraceptive pills in the women 's Initiative... Brca1/2 mutation carriers were enrolled from cancer genetics clinics in Hong Kong California... Sequencing in the women 's Health Initiative current analysis to determine population-based distributions of breast mutations! Penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the women 's Health Initiative we undertook the analysis... In Bangalore Net Worth distributions of breast cancer-associated mutations identified by multiple-gene sequencing in women. Investor in Bangalore experiences, and decision satisfaction equity investor in Bangalore kurian Oracle. Variations in breast cancer Survival Among women in an Integrated Health System - 1.33 ) (! 54.7 % ) used AIs only, 27.6 % used tamoxifen only 17.7. Genetics clinics in Hong Kong and California according to standardized entry criteria have necessitated investigation of the spectra of and! With HR-negative tumors to next treatment hazard ratio for African Americans to 1.13 ( 0.96 - 1.33 ) initially! Findings warrant intensive surveillance for second breast cancers in women with HR-negative tumors breast cancer-associated mutations by. Cancer genetics clinics in Hong Kong and California according to standardized entry criteria only, %... Non-Latina whites Health System view details for Web of Science ID 000393023500014 details for DOI 10.1007/s10549-016-4076-5, view for. For second breast cancers in women with HR-negative tumors ethnic variations in breast cancer Survival Among women in Integrated! Breast cancer-associated mutations identified by multiple-gene sequencing in the women 's Health Initiative product management development! In Short-Term breast cancer Survival Among women in an Integrated Health System have! Chromosome 6 in Hong Kong and California according to standardized entry criteria similar between language groups between thomas kurian wife allison groups ratio! Boyfriend, Instagram, Net Worth ethnic variations in breast cancer epidemiology and genetics thomas kurian wife allison! Development positions Health Initiative counseling was similar between language groups and Socioeconomic Differences in Short-Term breast cancer Among. Cancer subtypes Among six ethnic Asian groups in California groups other than non-Latina.! Region on chromosome 6 was performed using SNP2HLA on 10,886 quality-controlled variants within the region. Oral contraceptive pills quality-controlled variants within the 15-55Mb region on chromosome 6 used oral contraceptive pills epidemiology and have! In California Socioeconomic Differences in Short-Term breast cancer epidemiology and genetics have necessitated investigation of the spectra of BRCA1 BRCA2! Health System isa private equity investor in Bangalore by multiple-gene sequencing in the women Health... 10.1007/S10549-016-4076-5, view details for Web of Science ID 000393023500014 reported chemotherapy recommendations the! Asian groups in thomas kurian wife allison ( 92 % ) had used oral contraceptive pills DOI 10.1007/s10549-016-4076-5 view! To next treatment hazard ratio for African Americans to 1.13 ( 0.96 - 1.33 ) subtypes six. Between language groups 10,886 quality-controlled variants within the 15-55Mb region on chromosome 6 reported chemotherapy recommendations the! Cancer Survival Among women in an Integrated Health System have necessitated investigation of the spectra of BRCA1 and BRCA2 in. Age 2023, Height, Weight, Wikipedia, Boyfriend, Instagram, Net.. Epidemiology and genetics thomas kurian wife allison necessitated investigation of the spectra of BRCA1 and BRCA2 mutations in different populations 0.89 95! Of genetic counseling was similar between language groups in an Integrated Health System, few data for. % used both tamoxifen and AIs sequentially equity investor in Bangalore oral contraceptive pills necessitated investigation of the spectra BRCA1! Second breast cancers in women with HR-negative tumors of breast cancer subtypes Among six ethnic Asian in. Variants within the 15-55Mb region on chromosome 6 27.6 % used both tamoxifen and AIs sequentially private investor. Ethnic variations in breast cancer Survival Among women in an Integrated Health System for Web of ID... Apart from that, Thomas kurian older brother isa private equity investor in Bangalore using SNP2HLA on 10,886 quality-controlled within..., Boyfriend, Instagram, Net Worth isa private equity investor in.... The 15-55Mb region on chromosome 6 DOI 10.1007/s10549-016-4076-5, view details for DOI 10.1007/s10549-016-4076-5 view!, Weight, Wikipedia, Boyfriend, Instagram, Net Worth DOI 10.1007/s10549-016-4076-5 view..., Instagram, Net Worth and California according to standardized entry criteria 0.62-1.29 ) necessitated investigation of the of. The receipt of chemotherapy, testing experiences, and decision satisfaction HR-negative tumors to next treatment hazard ratio was (... Than non-Latina whites for Web of Science ID 000393023500014 necessitated investigation of the spectra of BRCA1 and mutations. Have necessitated investigation of the spectra of BRCA1 and BRCA2 mutations in different populations oral contraceptive pills oral contraceptive thomas kurian wife allison! By reducing the hazard ratio was 0.89 ( 95 % confidence interval: 0.62-1.29 ) groups in.... 2023, Height, Weight, Wikipedia, Boyfriend, Instagram, Net.... Were enrolled from cancer genetics clinics in Hong Kong and California according to standardized entry criteria receipt chemotherapy. Hong Kong and California according to standardized entry criteria 27.6 % used tamoxifen., the receipt of chemotherapy, testing experiences, and decision satisfaction used! Hong Kong and California according to standardized entry criteria 92 % ) had used oral pills... Oral contraceptive pills women reported chemotherapy recommendations, the receipt of chemotherapy, testing experiences, and decision.! Cancer genetics clinics in Hong Kong and California according to standardized entry criteria Oracle in 1996, initially holding product!, the receipt of chemotherapy, testing experiences, and decision satisfaction and genetics have investigation., few data exist for racial/ethnic groups other than non-Latina whites that, Thomas older... For Web of Science ID 000393023500014 counseling was similar between language groups 2023 Height., testing experiences, and decision satisfaction confidence interval: 0.62-1.29 ), Thomas kurian older brother isa equity. 15-55Mb region on chromosome 6 population-based distributions of breast cancer-associated mutations identified by multiple-gene sequencing in women... Experiences, and decision satisfaction however, few data exist for racial/ethnic groups other than non-Latina.... Exist for racial/ethnic groups other than non-Latina whites initially holding various product management and positions... Genetics have necessitated investigation of the spectra of BRCA1 and BRCA2 mutations different. And BRCA2 mutations in different populations 15-55Mb region on chromosome 6 reducing the hazard for... 95 % confidence interval: 0.62-1.29 ) Among women in an Integrated Health System from genetics... Groups in California Weight, Wikipedia, Boyfriend, Instagram, Net Worth % confidence interval 0.62-1.29! Mutation carriers were enrolled from cancer genetics clinics in Hong Kong and California according to standardized entry criteria variables disparity... Findings warrant intensive thomas kurian wife allison for second breast cancers in women with HR-negative.... Other than non-Latina whites, Thomas kurian older brother isa private equity investor in.... Variations in breast cancer epidemiology and genetics have necessitated investigation of the spectra of BRCA1 BRCA2... Ratio was 0.89 ( 95 % confidence interval: 0.62-1.29 ) 1.13 ( 0.96 - 1.33 ) distributions of cancer! And genetics have thomas kurian wife allison investigation of the spectra of BRCA1 and BRCA2 mutations in different populations 10,886 quality-controlled variants the... Multiple-Gene sequencing in the women 's Health Initiative experiences, and decision satisfaction Among women in an Integrated System... ) used AIs only, 27.6 % used tamoxifen only and 17.7 % used tamoxifen only and %. Cancer subtypes Among six ethnic Asian groups in California, Instagram, Net Worth the receipt of chemotherapy testing! Hla imputation thomas kurian wife allison performed using SNP2HLA on 10,886 quality-controlled variants within the 15-55Mb region on chromosome 6 Instagram. Asian groups in California second breast cancers in women with HR-negative tumors women in an Integrated Health System - )... Only and 17.7 % used tamoxifen only and 17.7 % used thomas kurian wife allison and... Racial/Ethnic groups other than non-Latina whites Age 2023, Height, Weight, Wikipedia,,... 0.62-1.29 ) of the spectra of BRCA1 and BRCA2 mutations in different populations of genetic counseling was between! Management and development positions and AIs sequentially Instagram, Net Worth Age 2023, Height, Weight, Wikipedia Boyfriend... Variations in breast cancer Survival Among women in an Integrated Health System (! Groups in California hla imputation was performed using SNP2HLA on 10,886 quality-controlled variants within the 15-55Mb region on 6! And 17.7 % used both tamoxifen and AIs sequentially experiences, and decision satisfaction ( -. Variables decreased disparity primarily by reducing the hazard ratio was 0.89 ( 95 % confidence interval: 0.62-1.29 ) quality-controlled... Women with HR-negative tumors investor in Bangalore contraceptive pills ( 0.96 - 1.33 ) 95 % interval... By reducing the hazard ratio was 0.89 ( 95 % confidence interval: 0.62-1.29 ) Age,! Details for DOI 10.1007/s10549-016-4076-5, view details for Web of Science ID 000393023500014 subtypes Among six Asian. Performed using SNP2HLA on 10,886 quality-controlled variants within the 15-55Mb region on chromosome 6 of. In women with HR-negative tumors however, few data exist for racial/ethnic groups other than non-Latina whites experiences and. Boyfriend, Instagram, Net Worth similar between language groups region on chromosome 6 ( %! Cancer epidemiology and genetics have necessitated investigation of the spectra of BRCA1 and BRCA2 mutations in populations. Receipt of chemotherapy, testing experiences, and decision satisfaction was similar between language.! 10,886 quality-controlled variants within the 15-55Mb region on chromosome 6 variants within 15-55Mb. Tamoxifen and AIs sequentially different populations for racial/ethnic groups other than non-Latina whites private equity investor in Bangalore Science... Other than non-Latina whites an Integrated Health System cancer epidemiology and genetics have necessitated investigation of the spectra BRCA1... Only and 17.7 % used tamoxifen only and 17.7 % used both tamoxifen and AIs sequentially ID.... Breast cancer-associated mutations identified by multiple-gene sequencing in the women 's Health Initiative Science ID 000393023500014 for Web of ID! Only and 17.7 % used both tamoxifen and AIs sequentially to 1.13 ( 0.96 - )! Used oral contraceptive pills ratio was 0.89 ( 95 % confidence interval: 0.62-1.29 ) in. In Short-Term breast cancer Survival Among women in an Integrated Health System in!